TB Alliance Expands Discovery Projects with GlaxoSmithKline
The TB Alliance and GlaxoSmithKline (GSK) announced that they would jointly pursue a broad drug discovery program to improve the
TB Control: Challenges Ahead
“Tuberculosis was last year’s most overlooked tragedy. TB killed more people than all wars, earthquakes, floods, tsunamis, airline accidents, terrorist
The British Department for International Development (DFID) Outlines Role Pharmaceutical Industry Can Play in Access to Essential Medicines
The UK Government recently launched a new framework document entitled “Increasing people’s access to essential medicines in developing countries.” The
Developing Countries Innovating for Global Health
A recent article published in Innovation Strategy Today highlights the growing importance and potential impact that developing countries can have
Event Spotlight: Gordon Research Conference on TB Drug Development
Established in the late 1920s, the Gordon Research Conferences provide an arena for dialogue on frontier research in the biological,
The Vision Behind the Compound: PA-824 Architects
William Baker discovered his passion for chemistry the first time he saw the crystals of a drug molecule through the
Research of neglected diseases gets shot in arm
At a laboratory near Madrid, where the air pressure is reduced to prevent air leaks, corporate scientists in protective suits
World TB Day 2005
World TB Day 2005 Media Call with GlaxoSmithKline on Wednesday, March 23, 2005 (10:30 a.m. EST) TB Alliance Announces New
Better Drugs for Tuberculosis
Drug discovery partnership aims to speed search for improved treatments Coinciding with world TB Day on March 24, the nonprofit